PAA 2.94% 16.5¢ pharmaust limited

Ann: Positive Phase 1 MEND Study Top-Line Results, page-5

  1. 1,070 Posts.
    lightbulb Created with Sketch. 192
    Does this mean the disease progression has been halted?

    There were no significant differences in ALSFRS-R scores between pre-dose and end of treatment for all 12
    patients (p=0.78), Cohort 1 (p=0.41), and Cohort 2 (p=0.88) suggesting that treatment with monepantel over 8 –
    12 months slowed the rate of disease progression.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $80.25M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $70.28K 418.6K

Buyers (Bids)

No. Vol. Price($)
5 217323 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 43978 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.